Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Domestic banks better placed as mass sell-off continues, says RBC

(Sharecast News) - RBC Capital Markets has said that domestic lenders are better positioned in the midst of the current global equity market sell-off, with share prices in the European banking sector having tanked over recent days. European bank stocks have fallen by 14% since last Wednesday - the day when Donald Trump unleashed sweeping trade tariffs that have hammered investor sentiment and raised recessionary risks across the globe. Euro-area banks have dropped by 19% with lenders with heavy exposure to Asia and the US having performed the worst.

Across the sector, banks are now trading at a 22% discount to their price-to-earnings historic average, while the cost of equity stands around 100 basis points above historic averages at 12.3%, RBC said.

"Within a short period of time, the fortunes of European banks have changed as expectations on the economic outlook have drastically changed," the broker said in a research note on Monday. "Knock on effects of tariffs are potential meaningful earnings headwinds to banks. Things are evolving though and for now it appears that some of the domestically focused banks are better placed on a relative basis."

The direct impact of tariffs is limited for the sector so far, but banks are highly geared to the "secondary effect", RBC said.

"If implemented the impact will be felt differently across regions impacting banks depending on geographic exposure with Asia (HSBC, UBS, Baer), Germany (DBK, CBK), Mexico (BBVA), US (Barclays, UBS) in the spotlight but also Ireland and Switzerland given their level of exports to the US.

"Domestically orientated banks appear to be somewhat more isolated for now. Events will be evolving with possible retaliatory measures which could impact the services sector (e.g., financial services; see EBA report on third country players)."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.